Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 95 results for "sudhir agrawal"

Invest in ultra short-term and short-term income funds current...

''Yield curve to steepen in April due to expectations of improvement in the liquidity situation,'' says Sudhir Agrawal, Fund Manager, UTI MF. In an interview with Varsha Inamdar of, Sudhir Agrawal said, ''Investors should focus on the ... MyIris, 2 weeks ago
Bidness Etc

Idera spikes as its up-and-down TLR program comes through in PhII

Idera Pharmaceuticals CEO Sudhir Agrawal After setbacks in cancer and respiratory disease, Idera Pharmaceuticals ($IDRA) has finally found some success with its toll-like receptor (TLR) program, touting encouraging results from a Phase II trial on ...
 FierceBiotech3 weeks ago Idera Pharmaceutical Up After Market; Big Moves in Agios and Idenix  Bidness Etc1 week ago Idera Presents Preclinical Data at AACR Showing IMO-8400 Inhibits Tumor Growth and Survival Signaling in B-cell Lymphoma Cells with Oncogenic MYD88 L265P Mutation  Business Wire1 week ago Idera Pharmaceuticals announces positive data from Phase II psoriasis trial  PredictWallStreet1 week ago

Complaint against doc for 'sheltering' prisoner

AHMEDABAD: The service tax commissioner on Thursday filed a complaint against Dr R M Agrawal of Chandramani Hospital in Shahibaug for hospitalizing an accused person by 'fabricating' medical papers to keep him out of Sabarmati jail. The complaint ...
 Times of India1 month ago

High volatality in bond market spurs rate futures

MUMBAI: The heightened volatility in the government bond market has prompted large entities to participate actively in the interest rate futures (IRFs) as they hedge their trading positions. Since April 7, the daily trading volumes on the NSE ...
 Economic Times3 days ago

Idera announces encouraging preclinical data from B-cell lymphoma study

Idera Pharmaceuticals, Inc., a biopharmaceutical company, has announced new preclinical data demonstrating the ability of its Toll-like receptor, or TLR, antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell lymphoma cells ...
 Individual.com5 days ago IDERA PHARMACEUTICALS : Reports Preclinical Data at AACR  4 Traders1 week ago Idera Reports Preclinical Data at AACR  Individual.com1 week ago

Phase -5: Candidates Asset, Education Details

Name State Constituency Party Name Movable Assets (Rs) Immovable Assets (Rs) Total Assets (Rs) Nandan Nilekani Karnataka Bangalore South INC 76,65,95,17,41 44,34,39,808 77,10,29,57,219 Anil Kumar Sharma Bihar Jahanabad JD(U) ...
 New Indian Express1 week ago

Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on..

/PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Arrowhead Research Corp. (NASDAQ: ARWR), Providence Service Corp. (NASDAQ: PRSC), Durata Therapeutics, Inc. (NASDAQ: DRTX), Orthofix International N.V. (NASDAQ: OFIX), ...
 ADVFN India2 weeks ago ORTHOFIX NV : Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera  4 Traders2 weeks ago
4 Traders

IDERA PHARMACEUTICALS : IDRA) Climbs on Positive Top-line Data from IMO-8400 Phase 2 Trial

It's been a wild week for Idera Pharmaceuticals (IDRA) . What started as a modest decline on March 19 after the stock bumped against its rising resistance level at about $6.85 a share turned into a blood bath on Monday when Summer Street Capital ...
 4 Traders3 weeks ago Idera Pharmaceuticals (IDRA) Climbs on Positive Top-line Data from IMO-8400 Phase 2 Trial  HispanicBusiness.com3 weeks ago
My Mobile


Written by My Mobile Team 27 Mar 2014 at 5 hours ago The Indian telecom industry is one of the biggest in the world. Ensuring that the Indian consumer has their share of mobile connectivity and convenience are hundreds of thousands of people ...
 My Mobile3 weeks ago

Nagpur University again changes lawyer pleading case against banned colleges

NAGPUR: The Nagpur University's inefficient administration is infamous for its timidity. In the latest instance, NU has roped in senior counsel Avinash Gordey to plead the case on 250 banned colleges and removed Sudhir Puranik, who was pleading the ...
 Times of India3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sudhir agrawal
Get updated on latest news & your favorite topics right in your inbox!
More     Less